Preferred Label : Hurler syndrome;
CISMeF acronym : MPS1-H;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Mucopolysaccharidosis type ih; MPS1-H;
Description : The mucopolysaccharidoses are a group of inherited disorders caused by a lack of specific
lysosomal enzymes involved in the degradation of glycosaminoglycans (GAGs), or mucopolysaccharides.
The accumulation of partially degraded GAGs causes interference with cell, tissue,
and organ function. Deficiency of alpha-L-iduronidase can result in a wide range of
phenotypic involvement with 3 major recognized clinical entities: Hurler (MPS IH),
Scheie (MPS IS; 607016), and Hurler-Scheie (MPS IH/S; 607015) syndromes. Hurler and
Scheie syndromes represent phenotypes at the severe and mild ends of the MPS I clinical
spectrum, respectively, and the Hurler-Scheie syndrome is intermediate in phenotypic
expression (McKusick, 1972). MPS I is more frequent than MPS II (Hunter syndrome;
309900), which has no corneal clouding and pursues a slower course.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the alpha-L-iduronidase gene (IDUA, 252800.0001);
Laboratory abnormalities : Excretion of dermatan sulfate and heparan sulfate in urine;
Prefixed ID : #607014;
Origin ID : 607014;
UMLS CUI : C0086795;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)